Leaders in Regulatory Documentation
A review division forms its judgment from what is on the page: the protocol that defines the trial, the CSR that reports it, the summaries that argue the case. A document that buries its answer costs review cycles; a document built for the reviewer gives them what they need on the first read. Our senior medical writers turn data into documents that are easy to review, because in regulatory writing, clarity is speed.
Medical writing follows the arc of development. The four stages below cover the regulatory documents we author, from the first pre-IND briefing package to the last periodic safety report.
An ambiguous objective, an endpoint defined two ways, an eligibility criterion nobody can operationalize: protocol flaws replicate themselves into the statistical analysis plan, the CSR, and eventually the label. We write trial documents with the end in mind, drafting the protocol so the CSR can be written from it, and keeping the IB, consent forms, and safety reporting aligned through every amendment.
Between database lock and submission, writing becomes the critical path. We plan the document cascade backward from the filing date: CSR shells built before lock, key messages agreed before first draft, Module 2 summaries developed in parallel rather than in sequence, and integrated summaries scoped early enough to avoid the rework that sinks timelines. Our writers have carried NDA, BLA, and MAA workloads through the crunch, and know what an eCTD-ready document actually requires.
Every document runs the same five-stage process, sized to the document. It is how a draft arrives on schedule without ten rounds of review.
Scope, timeline, and reviewer map agreed; document shell and style conventions locked before writing starts.
Tables, figures, and listings reviewed with the team; key messages agreed before a single section is drafted.
A senior writer owns the draft and drives it to the plan, chasing inputs instead of waiting for them.
Consolidated comments, adjudication meetings for conflicts, and clean version control across review rounds.
Independent quality control against source data, editorial pass, and formatting that survives eCTD publishing.
Post-approval documents run on regulatory clocks that do not move: PBRER data lock points, RMP updates triggered by new safety findings, labeling revisions that cascade through every market's local documents. We maintain the periodic safety calendar, keep core documents and their regional variants aligned, and write the label negotiations documents where a single sentence can be worth a market.
EU CTR lay summaries, clinical trial registration, results disclosure, and document anonymization have turned "internal" documents into published ones. We write plain-language summaries that non-scientists actually understand, prepare documents for publication under EMA Policy 0070 and Health Canada PRCI, and keep registry postings consistent with what the protocol and CSR really say.
Two situations call for more than a writer: a submission sprint that is already behind, and a documentation function that needs to be built rather than staffed.
Documents fall behind for predictable reasons: a departed writer, an underestimated ISS, review cycles that never converge. We triage the document set against the filing date, re-plan the cascade, put senior writers on the critical path, and run the review process with the discipline it lost. Rescue is a project type we plan for, not an emergency we improvise.
If every document starts from a blank page, every document is late. We build the infrastructure that makes writing repeatable: template libraries mapped to ICH and agency guidance, style guides and lexicons that end formatting debates, narrative automation approaches for high-volume documents, and the SOPs that let an internal team run the process without us.
Our medical writers hold advanced degrees and have owned documents through real filings: the lock-to-submission sprints, the information requests at day 74, the label negotiations at the end. You get an author who drives the document, not a scribe who waits for input.
PhDs, PharmDs, and MDs who read the data themselves, challenge inconsistencies before regulators find them, and hold their own in a room of investigators.
Writers who have carried NDA, BLA, and MAA document sets through database lock, agency questions, and approval, and know which shortcuts cost review cycles.
ICH E3 and M4 structure, CORE Reference, AMA style, GPP 2022, EU CTR transparency rules, and the document conventions each review division actually expects.
A single protocol, a submission's full document cascade, or a standing outsourced writing function, with the same senior standard at every scale.
Tell us what needs to be written and when it is due. We'll match you with a senior medical writer in the right therapeutic area and respond within one business day. All inquiries are strictly confidential.
Our team's perspectives on document strategy, submission writing, and what makes a reviewer's job easier: coming soon. In the meantime, reach out directly with a question you'd like to see addressed.
The structural choices that let a reviewer find the answer before they find a question.
Why integrated summaries sink timelines, and the planning milestones that prevent it.
Writing for the public without overstating, understating, or triggering a compliance finding.